MedGenome, a global precision medicine company specializing in omics solutions, has appointed Martin Dewhurst, a veteran with over 30 years at McKinsey, as the Chairman of its Advisory Board. Martin’s extensive experience in the life sciences space will play a crucial role in guiding and advancing MedGenome’s mission of leveraging omics to address global healthcare needs. As Chairman of the Advisory Board, Martin will work closely with MedGenome’s Research services team in the US, fostering collaboration with global life sciences communities and guiding the company’s omics research initiatives. His appointment aligns with MedGenome’s commitment to developing an ecosystem reflective of global healthcare consumers.
Dr. Felix Olale, Chairman of MedGenome’s Board of Directors, expressed excitement about Martin Dewhurst joining as the Chair of the Advisory Board, stating that his strategic vision and experience will strengthen MedGenome’s position as a leader in the global omics space. Mahesh Pratapneni, Group CEO & Co-founder of MedGenome, sees Martin’s track record and understanding of the global healthcare landscape as invaluable, anticipating his guidance in building relationships with the scientific community and strengthening MedGenome’s position as a trusted omics solutions provider globally.
Martin Dewhurst believes that omics will anchor the future of the life sciences sector, and he is excited to contribute to MedGenome’s growth in the global omics market. With a focus on fostering growth and innovation, Martin plays crucial roles across growth VC investing with Lightrock, M&A advisory at PJT, and holds board/advisor positions for dynamic growth companies.
Martin led McKinsey’s global life sciences practice for seven years, covering diverse sectors from pharmaceuticals to consumer health. He co-founded and led the McKinsey Health Institute (MHI), a non-profit entity addressing global health challenges. His extensive tenure at McKinsey, spanning more than three decades, included leading McKinsey’s Organization practice in EMEA, managing aspects such as human capital, transformation, and post-merger integrations. Martin’s background includes work across geographies in Europe, the US, Asia, the Middle East, and South Africa.
Read More: Click Here